Namibia suspends use of Russia’s Sputnik V vaccine due to concerns of HIV infection.

0 0
Read Time:53 Second

The African country announced on Saturday that the health experts and government officials studied the reports of negative effects of the Sputnik vaccine and therefore decided to discontinue the use of Sputnik V.

This decision was “out of [an] abundance of caution that men [who] received Sputnik V may be at higher risk of contracting HIV,” Namibia’s health ministry said in a statement.

Suspension of the vaccine in Namibia comes a few days after South African Health Product Regulatory Authority (SAHPRA) declared that it will not be approving Russia’s Sputnik V vaccine.

SAPHRA claimed that Sputnik V carries the risk of increasing risk of HIV infection among men. “Use of the Sputnik V vaccine in South Africa, a setting of a high HIV prevalence and incidence, may increase the risk of vaccinated males acquiring HIV,” the South African Health Product Regulatory Authority (SAHPRA) said in a statement.

However, the Russian manufacturer, Gamaleya Centre, has rubbished these reports and has called these claims to be ‘unfounded’, while vowing to bring evidence to prove SAPHRA wrong.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published.